Adverse Events of the Port Delivery System and Addressing Challenges with Adoption
Panelists discuss how careful patient selection and management of potential complications - including surgical risks, device-related adverse events, and cost-benefit considerations requiring operating room resources - are crucial factors in successfully implementing the port delivery system in clinical practice.
Video Player is loading.
Video content above is prompted by the following:
- What are the major adverse effects associated with the PDS, and which patients are not suitable candidates for this delivery system?
- What are some potential challenges to the adoption of the PDS, and how can retina specialists and surgeons address these to facilitate its integration into clinical practice?
- Need to go to the operating room- balancing cost versus benefits
Recent Videos
Impact of Durable Therapies on Patients and Clinics and Monitoring Strategies
Snowmass Retina & Eye 2025: Ronald Frenkel, MD, previews the unique agenda with a fusion of retina, cataract, and glaucoma
Strategies for Loading Dose Sse for Treatment-Naive and Switch Patients
Perspectives on the Usefulness of Real-world Data
Safety Profile of New Therapies
Outcomes with Faricimab and Choosing Between the New Therapies
Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies
Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal Diseases
Faricimab Molecular Design and Role of Ang-2
Patient Selection for Aflibercept 8 mg
Related Content
